Novavax NVAX Stock
$9.00
0.000000%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.48B
LOW - HIGH [24H]
$8.81
-
$9.59
VOLUME [24H]
$4.12M
P/E Ratio
0
Earnings per share
-$0.56
ISIN
US6700024010
Novavax Price Chart
Novavax NVAX Financial and Trading Overview
| Novavax stock price | 9 USD |
| Previous Close | 9.13 USD |
| Open | 9.16 USD |
| Bid | 8.1 USD x 200 |
| Ask | 11.57 USD x 200 |
| Day's Range | 8.97 - 9.36 USD |
| 52 Week Range | 6.13 - 11.97 USD |
| Volume | 3.69M USD |
| Avg. Volume | 4.65M USD |
| Market Cap | 1.48B USD |
| Beta (5Y Monthly) | 2.414 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.11 USD |
NVAX Valuation Measures
| Enterprise Value | 984.67M USD |
| Trailing P/E | N/A |
| Forward P/E | -16.586498 |
| PEG Ratio (5 yr expected) | 1.32 |
| Price/Sales (ttm) | 2.4817185 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.651 |
| Enterprise Value/EBITDA | 16.54 |
Trading Information
Novavax Stock Price History
| Beta (5Y Monthly) | 2.414 |
| 52-Week Change | 44.69% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 11.97 USD |
| 52 Week Low | 6.13 USD |
| 50-Day Moving Average | 9.05 USD |
| 200-Day Moving Average | 8.47 USD |
NVAX Share Statistics
| Avg. Volume (3 month) | 4.65M USD |
| Avg. Daily Volume (10-Days) | 4.64M USD |
| Shares Outstanding | 164.44M |
| Float | 141.47M |
| Short Ratio | 7.31 |
| % Held by Insiders | 5.00% |
| % Held by Institutions | 69.57% |
| Shares Short | 45.97M |
| Short % of Float | 28.12% |
| Short % of Shares Outstanding | 27.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -14.72% |
| Operating Margin (ttm) | -7.18% |
| Gross Margin | 27.49% |
| EBITDA Margin | 9.98% |
Management Effectiveness
| Return on Assets (ttm) | 1.99% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 596.34M USD |
| Revenue Per Share (ttm) | 3.67 USD |
| Quarterly Revenue Growth (yoy) | -79.10% |
| Gross Profit (ttm) | 163.96M USD |
| EBITDA | 59.53M USD |
| Net Income Avi to Common (ttm) | -87835000 USD |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 790.33M USD |
| Total Cash Per Share (mrq) | 4.81 USD |
| Total Debt (mrq) | 295.06M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.484 |
| Book Value Per Share (mrq) | -0.88 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -91556000 USD |
| Levered Free Cash Flow (ttm) | 58.57M USD |
Profile of Novavax
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 21 Firstfield Road |
| ZIP | 20878 |
| Phone | 240 268 2000 |
| Website | https://www.novavax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 749 |
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Q&A For Novavax Stock
What is a current NVAX stock price?
Novavax NVAX stock price today per share is 9 USD.
How to purchase Novavax stock?
You can buy NVAX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novavax?
The stock symbol or ticker of Novavax is NVAX.
Which industry does the Novavax company belong to?
The Novavax industry is Biotechnology.
How many shares does Novavax have in circulation?
The max supply of Novavax shares is 164.44M.
What is Novavax Price to Earnings Ratio (PE Ratio)?
Novavax PE Ratio is now.
What was Novavax earnings per share over the trailing 12 months (TTM)?
Novavax EPS is -0.56 USD over the trailing 12 months.
Which sector does the Novavax company belong to?
The Novavax sector is Healthcare.
Novavax NVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
Dow Jones U.S. Biotechnology In
DJUSBT
US
|
3033.18 USD — |
+1.08
|
100.05M USD — | 3015.75 USD — | 3040.05 USD — | — - | 100.05M USD — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
6750.7 USD — |
+0.85
|
— — | 6680.28 USD — | 6803.27 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
US Tech Next Generation 100 Inde
NGX
US
|
1787.88 USD — |
-1.19
|
— — | 1779 USD — | 1802.31 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6185.56 USD — |
+0.85
|
— — | 6121.03 USD — | 6233.73 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}